FDA Inspection
Incinta Fertility Center, LLCIncinta Fertility Center, LLC – FDA Inspection, May 2, 2023
Record Details
This FDA Inspection record concerns Incinta Fertility Center, LLC, with an inspection on May 2, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · af100a4e-eeb0-48f7-b2d2-5defcd485ee7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1204431
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 1271.90(c)Eligibility not required--warning labels
- 21 CFR 1271.60(a)Completion of eligibility determination
- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
- 21 CFR 1271.60(a)Completion of eligibility determination
- 21 CFR 1271.90(c)Eligibility not required--warning labels
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Incinta Fertility Center, LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 24, 2025 | VAI | Los Angeles District Office | Human Cellular, Tissue, and Gene Therapies |
| March 3, 2022 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Incinta Fertility Center, LLC
- FDA Inspection 1261683 - 2025-02-24
- FDA Inspection 1164284 - 2022-03-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.